
Loading, please wait...

Loading, please wait...

Gautam Adani recently launched a landmark vision care in Bihar initiative to address rural health challenges. This ambitious project focuses on providing affordable treatment and building a sustainable healthcare ecosystem in the region. Consequently, the Adani Akhand Jyoti Foundation seeks to restore sight and dignity to underserved communities. Furthermore, the initiative targets the completion of 3.3 lakh eye surgeries annually. This effort will significantly reduce the burden of preventable blindness in the Hindi heartland.
The project establishes two primary facilities: the Adani Centre for Eye (ACE) and Adani Training in Ophthalmic Medicine (ATOM). Specifically, ACE handles complex surgical procedures and advanced treatments. Meanwhile, ATOM focuses on essential workforce development. It will train 1,000 eye health professionals, including optometrists and assistants, every year. Moreover, this dual approach ensures that infrastructure growth matches the availability of skilled personnel. Additionally, the group plans to establish a 200-bed hospital in the Bhagalpur district to serve eastern Bihar.
The Adani family has committed significant resources to this long-term mission. Initially, the project received Rs 150 crore for immediate development in Bihar. However, Gautam Adani later announced an additional personal commitment of Rs 500 crore to scale the mission nationwide. Consequently, the total investment outlay will exceed Rs 700 crore. This investment reflects a broader vision of nation-building through social service and healthcare excellence. Similarly, the foundation continues to support various rural outreach programs across eleven states in India.
Q1: What is the primary goal of the Adani Centre for Eye (ACE)?
ACE aims to provide advanced treatment and surgical facilities focused on affordable care and large-scale rural outreach in Bihar.
Q2: How many eye health professionals will be trained annually?
The initiative plans to train 1,000 eye health professionals every year through the Adani Training in Ophthalmic Medicine (ATOM) facility.
Q3: What is the total investment commitment for this vision care project?
The total investment outlay, including operational expenditure, is expected to exceed Rs 700 crore across its expansion phases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Gautam Adani initiates a Rs 150 crore vision care project in Bihar to provide affordable eye surgeries and train 1,000 healthcare professionals annually....
2 months ago

New research shows that common food emulsifiers like soy lecithin and DATEM disrupt gut barrier integrity, induce cytotoxicity, and activate TNF and NF-κB inflammatory pathways. They also promote IgE production, offering insight into the rise of food allergies and gastrointestinal inflammatory conditions.
Today

A study in Colombo, Sri Lanka reveals that 39.8% of lifetime pregnancies among female sex workers were unintended. Early entry into sex work and higher parity were key risk correlates, emphasizing the need for outreach pregnancy testing and rapid access to contraception.
Today

A cross-sectional analysis from the Electronic Framingham Heart Study reveals that a higher daily heart rate per step ratio is associated with lower composite cognitive scores in older adults, highlighting smartwatch metrics as valuable tools for detecting subclinical cardiovascular factors linked to brain health.
Today

A cadaveric study compares the biomechanical strength, load-to-failure, and stiffness of tape-augmented all-soft tissue quadriceps tendon autografts against quadrupled semitendinosus constructs in ACL reconstruction, providing crucial insights for orthopaedic surgeons regarding graft selection and fixation.
Today

Preclinical toxicology of an equimolar D-beta-hydroxybutyrate (D-BHB) formulation for long-chain fatty acid oxidation disorders established a minipig NOAEL of 500 mg/kg BID (1000 mg/kg/day). Key acute findings included transient hypertension, tachycardia, QTc prolongation, and diarrhea at high doses.
Today